Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10032460 | American Journal of Obstetrics and Gynecology | 2005 | 8 Pages |
Abstract
Estrogen remains the primary bone active agent in hormone therapy, while progestins have significantly less activity. The selection of the appropriate progestin in hormone therapy should be based on criteria other than bone activity.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
James H. MD, Ken N. MD, MPH,